April 23, 2024 11:20 AM EDT
News Briefing

Brise rais­es $20M; Taro share­hold­er crit­i­cizes Sun Phar­ma deal

ENDPOINTS

Plus, news about Tar­sus Phar­ma­ceu­ti­cals and Bio­haven:

Brise Phar­ma­ceu­ti­cals rais­es $20M: The fund­ing comes from Shunxi Fund, Sher­pa Health­care Part­ners and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Will CRISPR mat­ter?

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times